<DOC>
	<DOCNO>NCT02591732</DOCNO>
	<brief_summary>The purpose study describe characteristic patient treat different OATs whether characteristic differ treatment . Furthermore describe persistence OAT risk bleed initiate OAT .</brief_summary>
	<brief_title>A Nationwide Registry Study Patients With Nonvalvular Atrial Fibrillation Initiating Oral Anticoagulation Therapies In The Early Period Following Apixaban Marketing In Denmark</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Apixaban</mesh_term>
	<criteria>The study population consist patient Denmark meet follow criterion : Adult ( â‰¥18 year ) time anticoagulant initiation Diagnosed atrial fibrillation without record valvular disease Initiated new OAT study period ( January 1 , 2011 December 31 , 2014 ) . For identification NVAF case , appearance least one hospital discharge diagnosis AF search database . Patients prosthetic heart valve , rheumatic mitral aortic valve disorder , mitral aortic stenosis exclude</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>